GALA RENEE D has filed 26 insider transactions across 3 companies since March 2023.
Most recent transaction: a tax payment of 7065 shares of Jazz Pharmaceuticals plc ($JAZZ) on March 05, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & CEO | F | Ordinary Shares | 7065 | $188.69 | 152,630.0000 | 61,606,000 | 4.42% | 0.01% |
| Feb. 26, 2026 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & CEO | A | Ordinary Shares | 44465 | $0.00 | 159,695.0000 | 61,606,000 | 38.59% | 0.07% |
| Jan. 16, 2026 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & CEO | A | Ordinary Shares | 12741 | $0.00 | 120,601.0000 | 61,606,000 | 11.81% | 0.02% |
| Jan. 16, 2026 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & CEO | F | Ordinary Shares | 5371 | $171.16 | 115,230.0000 | 61,606,000 | 4.45% | 0.01% |
| Dec. 5, 2025 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & CEO | F | Ordinary Shares | 80 | $166.91 | 107,860.0000 | 61,606,000 | 0.07% | 0.00% |
| Aug. 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & CEO | A | Ordinary Shares | 18808 | $0.00 | 107,869.0000 | 66,007,000 | 21.12% | 0.03% |
| May 8, 2025 | DEXCOM INC | $DXCM | GALA RENEE D | Director | A | Common Stock | 1161 | $0.00 | 6,881.0000 | 412,700,000 | 20.30% | 0.00% |
| May 8, 2025 | DEXCOM INC | $DXCM | GALA RENEE D | Director | A | Common Stock | 5074 | $0.00 | 10,794.0000 | 412,700,000 | 88.71% | 0.00% |
| March 6, 2025 | DEXCOM INC | $DXCM | GALA RENEE D | Director | A | Common Stock | 5720 | $0.00 | 5,720.0000 | 412,700,000 | 9999.99% | 0.00% |
| March 5, 2025 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | D | Ordinary Shares | 5704 | $138.95 | 88,895.0000 | 66,007,000 | 6.03% | 0.01% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | A | Ordinary Shares | 23111 | $0.00 | 83,044.0000 | 66,007,000 | 38.56% | 0.04% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | A | Ordinary Shares | 11555 | $0.00 | 94,599.0000 | 66,007,000 | 13.91% | 0.02% |
| Jan. 17, 2025 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | A | Ordinary Shares | 7741 | $0.00 | 63,233.0000 | 66,007,000 | 13.95% | 0.01% |
| Jan. 17, 2025 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | F | Ordinary Shares | 3300 | $122.62 | 59,933.0000 | 66,007,000 | 5.22% | 0.00% |
| Dec. 5, 2024 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | F | Ordinary Shares | 80 | $123.45 | 55,492.0000 | 67,511,000 | 0.14% | 0.00% |
| April 5, 2024 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | F | Ordinary Shares | 1736 | $115.21 | 55,357.0000 | 72,066,000 | 3.04% | 0.00% |
| March 5, 2024 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | F | Ordinary Shares | 3622 | $117.53 | 57,093.0000 | 72,066,000 | 5.97% | 0.01% |
| March 1, 2024 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | A | Ordinary Shares | 19916 | $0.00 | 60,715.0000 | 72,066,000 | 48.81% | 0.03% |
| Jan. 17, 2024 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | A | Ordinary Shares | 7079 | $0.00 | 44,003.0000 | 72,066,000 | 19.17% | 0.01% |
| Jan. 17, 2024 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | F | Ordinary Shares | 3204 | $119.13 | 40,799.0000 | 72,066,000 | 7.28% | 0.00% |
| Nov. 10, 2023 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | President & COO | A | Ordinary Shares | 772 | $0.00 | 36,887.0000 | 62,539,000 | 2.14% | 0.00% |
| June 8, 2023 | Gossamer Bio, Inc. | $GOSS | GALA RENEE D | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | EVP & Chief Financial Officer | S | Ordinary Shares | 6000 | $131.75 | 35,978.0000 | 62,539,000 | 14.29% | 0.01% |
| April 5, 2023 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | EVP & Chief Financial Officer | F | Ordinary Shares | 1807 | $145.78 | 41,978.0000 | 62,539,000 | 4.13% | 0.00% |
| March 5, 2023 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | EVP & Chief Financial Officer | F | Ordinary Shares | 1557 | $142.78 | 43,785.0000 | 62,539,000 | 3.43% | 0.00% |
| March 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | GALA RENEE D | EVP & Chief Financial Officer | A | Ordinary Shares | 12784 | $0.00 | 45,342.0000 | 62,539,000 | 39.27% | 0.02% |